SCHEMBL3062802

SCHEMBL3062802

CNc1c(I)c(C(=O)Cl)c(I)c(C(=O)Cl)c1I

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malonic Acid SCHEMBL11497552 0.90 LDHA (0.33) LMNA
SCHEMBL8905904 0.90 LIMK1 (0.36) LMNA
SCHEMBL9843247 0.80
SCHEMBL9843372 0.80
SCHEMBL9787607 0.80 ALDH1A1 (0.39)
SCHEMBL9009368 0.79 LMNA (0.43) LMNA
SCHEMBL5301790 0.78 LMNA (0.58) LMNA
SCHEMBL11708490 0.78 TSHR (0.41) LMNA
Hydrochloric Acid SCHEMBL4589564 0.77 LMNA (0.42) LMNA
SCHEMBL10714137 0.77 LIMK1 (0.41) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742926-A1 MACROCYCLE-SUBSTITUTED TRIMER HALOGEN-BENZOL DERIVATIVES Schering Aktiengesellschaft (DE) 2007-01-17 EP claimed
WO-2005108379-A1 MACROCYCLE-SUBSTITUTED TRIMER HALOGEN-BENZOL DERIVATIVES SCHERING AKTIENGESELLSCHAFT (DE) 2005-11-17 WO claimed
CN-104356023-A Preparation method of iotrolan WUHAN INST TECHNOLOGY 2015-02-18 CN disclosed
EP-2200656-B1 CONTRAST AGENTS GE HEALTHCARE AS (NO) 2012-12-05 EP disclosed
EP-2200656-B1 CONTRAST AGENTS GE HEALTHCARE AS (NO) 2012-12-05 EP disclosed
US-8323619-B2 Contrast agents GE HEALTHCARE AS (NO) 2012-12-04 US disclosed
US-8323619-B2 Contrast agents GE HEALTHCARE AS (NO) 2012-12-04 US disclosed
US-8323619-B2 Contrast agents GE HEALTHCARE AS (NO) 2012-12-04 US disclosed
US-8202511-B2 Contrast agents GE HEALTHCARE AS (NO) 2012-06-19 US disclosed
US-8202511-B2 Contrast agents GE HEALTHCARE AS (NO) 2012-06-19 US disclosed
US-8202511-B2 Contrast agents GE HEALTHCARE AS (NO) 2012-06-19 US disclosed
EP-0317492-A2 Substituted dicarboxylic acids-bis(3,5-dicarbamoyl-2,4,6-triiodo-anilides), process for their preparation and X-ray contrast agents containing them SCHERING AKTIENGESELLSCHAFT (DE) 1989-05-24 EP disclosed
EP-0308364-A2 Dicarboxylic acid-bis(3,5-dicarbamoyl-2-4-6-triiodanilides), process for their preparation and X-ray contrast agents containing them SCHERING AKTIENGESELLSCHAFT (DE) 1989-03-22 EP disclosed
EP-0160036-A4 NOVEL SYNTHETIC METHODS FOR NON-IONIC RADIOGRAPHIC CONTRAST MEDIA. BIOPHYSICA FOUNDATION (US) 1987-06-11 EP disclosed
EP-0160036-A1 NOVEL SYNTHETIC METHODS FOR NON-IONIC RADIOGRAPHIC CONTRAST MEDIA BIOPHYSICA FOUNDATION (US) 1985-11-06 EP disclosed
WO-1985001727-A1 NOVEL SYNTHETIC METHODS FOR NON-IONIC RADIOGRAPHIC CONTRAST MEDIA BIOPHYSICA FOUNDATION (US) 1985-04-25 WO disclosed
US-4367216-A X-RAYS, CONTRAST, OPACITY SCHERING AKTIENGESELLSCHAFT (DE) 1983-01-04 US disclosed
US-4364921-A RADIOPACITY SCHERING, AKTIENGESELLSCHAFT (DE) 1982-12-21 US disclosed
US-4352788-A ARTERIES BRACCO INDUSTRIA CHIMICA S.P.A. (IT) 1982-10-05 US disclosed
US-4239747-A Dicarboxylic acid bis(3,5-dicarbamoyl-2,4,6-triiodoanilides) useful as x-ray contrast agents SCHERING AKTIENGESELLSCHAFT (DE) 1980-12-16 US disclosed